Work

Anlotinib: First Global Approval

Year: 2018

Type: article

Source: Drugs

DOI: 10.1007/s40265-018-0939-x

Author: Yahiya Y. Syed

Institution: Springer Nature (New Zealand)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2810290331

FWCI: 11.75

Cites: 17

Cited by: 273

Related to: 10